Recent Advancements of Treatment for Leptomeningeal Carcinomatosis

Treatment of Leptomeningeal carcinomatosis (LMC) from solid cancers has not advanced noticeably since the introduction of intra-cerebrospinal fluid (CSF) chemotherapy in the 1970's. The marginal survival benefit and difficulty of intrathecal chemotherapy injection has hindered its wide spread u...

Descripción completa

Detalles Bibliográficos
Autores principales: Gwak, Ho-Shin, Lee, Sang Hyun, Park, Weon Seo, Shin, Sang Hoon, Yoo, Heon, Lee, Seung Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Neurosurgical Society 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534733/
https://www.ncbi.nlm.nih.gov/pubmed/26279806
http://dx.doi.org/10.3340/jkns.2015.58.1.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534733/
https://www.ncbi.nlm.nih.gov/pubmed/26279806
http://dx.doi.org/10.3340/jkns.2015.58.1.1

Ejemplares similares